Ocusphere Therapeutics Inc. is a biotech startup focused on gene therapy using non-viral vectors, targeting inherited retinal diseases.
Ocusphere Therapeutics Inc has raised $400K in total funding. The most recent round was Pre-Seed. The last funding was announced in February 2024.
Ocusphere Therapeutics Inc's investors include Hanxing Huang.
Ocusphere Therapeutics Inc is headquartered in Hayward, United States.
Ocusphere Therapeutics Inc. is a biotech startup focused on gene therapy using non-viral vectors, targeting inherited retinal diseases.
Ocusphere Therapeutics Inc is at the Pre-Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Ocusphere Therapeutics Inc — Funding & Investors." VCBacked, February 10, 2024, https://www.vcbacked.co/company/ocusphere-therapeutics-inc. Accessed September 30, 2026.
VCBacked. (2024). Ocusphere Therapeutics Inc — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/ocusphere-therapeutics-inc
{{cite web |title=Ocusphere Therapeutics Inc — Funding & Investors |url=https://www.vcbacked.co/company/ocusphere-therapeutics-inc |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated